Scientists identify faulty gene link to migraines
Migraine sufferers were offered new hope today after researchers identified a faulty gene responsible for the debilitating headaches.
The finding could lead to better treatment and improve the quality of life for the one in five people who have the neurological disorder.
Scientists at the University of Oxford along with colleagues in Canada took DNA samples from migraines sufferers and their families.
They found that if a gene called Tresk is defective it can trigger pain nerves in the brain and cause a severe headache.
The discovery explains why people in the same family often suffer from the condition and could lead to new drugs that can switch off the pain.
Dr Zameel Cader, from the Medical Research Council's Functional Genomics Unit at the University of Oxford, said: "We have now made a major step forward in our understanding of why people suffer with migraine and how in certain cases, your family can literally give you a headache.
"Previous studies have identified parts of our DNA that increase the risk in the general population but have not found genes which can be directly responsible for common migraine.
"What we've found is that migraines seem to depend on how sensitive our nerves are in the pain centres of the brain.
"This finding should help lead to the key player which controls this excitability and will give us a real opportunity to find a new way to fight migraines and improve the quality of life for those suffering."
A migraine is a severe, long-lasting headache usually felt as a throbbing pain at the front or on one side of the head.
Some people can have a warning visual disturbance - for example, seeing zigzag lines or flashing lights - before the start of the headache which is called an aura.
Many people also have symptoms, such as nausea and sensitivity to light, during the headache itself.
Until now, the genes responsible were unknown.
The World Health Organisation (WHO) rates migraine as a leading cause of disability worldwide and it is estimated to be the most costly neurological disorder in Europe.
The study, published in Nature Medicine, was funded by the Medical Research Council, Genome Canada, Genome Quebec, Emerillon Therapeutics, the Wellcome Trust and Pfizer.
Life & Style blogs
Childcare 'not just a women's issue,' says shadow minister as she sets out her 'dadifesto'
Who is Teresa Fidalgo? Debunking the fake ghost story that's got Instagram spooked
Scottish salmon sales leap as Asia develops a taste
Grim second life of the 'breastaurant': The oft-loathed sector is booming in the States thanks to Hooters, Twin Peaks and Tilted Kilt
Health: When masturbation can be fatal: The practice of auto-erotic asphyxia is often concealed by a coroner's verdict. Monique Roffey looks at a lethal taboo
- 1 President of Argentina adopts Jewish godson to 'stop him turning into a werewolf'
- 2 ALS ice bucket challenge co-founder Corey Griffin drowns, aged 27
- 3 Stoke-on-Trent becomes first British city to be classified as 'disaster resilient' by the United Nations
- 4 Sir Winston Churchill’s family begged him not to convert to Islam, letter reveals
- 5 AirAsia flight QZ8501 missing: Search for plane carrying 162 passengers from Indonesia to Singapore suspended overnight
£45000 - £55000 per annum: Recruitment Genius: This is an exciting opportunity...
£20000 per annum: Recruitment Genius: Panel Wireman required for small electro...
£25000 - £27000 per annum: Recruitment Genius: An SME based in East Cheshire, ...
£18000 - £22000 per annum: Recruitment Genius: Do you have previous experience...